BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33360157)

  • 1. Mechanisms underlie the proconvulsant effects of sildenafil.
    Zirak MR; Rahimian R; Mousavizadeh K; Dehpour AR
    Biomed Pharmacother; 2021 Feb; 134():111142. PubMed ID: 33360157
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxytocinergic system mediates the proconvulsant effects of sildenafil: The role of calcineurin.
    Rahimian R; Khoshneviszadeh M; Bahremand T; Zirak MR; Dehpour AR; Mousavizadeh K
    Horm Behav; 2020 Jun; 122():104753. PubMed ID: 32302594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current role of sildenafil in the management of erectile dysfunction].
    Akhvlediani ND; Matyukhov IP
    Urologiia; 2018 May; (2):142-146. PubMed ID: 29901310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourth Cranial Nerve Palsy Associated With Sildenafil Citrate.
    Lee Y; Park KA; Oh SY; Min JH; Kim BJ
    J Neuroophthalmol; 2021 Mar; 41(1):e79-e80. PubMed ID: 32235216
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erectile dysfunction, PDE5A inhibitors and melanoma].
    Schmutz JL
    Ann Dermatol Venereol; 2015 Dec; 142(12):800-1. PubMed ID: 26293983
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Transient Colorblindness With Sildenafil and Tadalafil.
    Rosen SM; Kaja S; De Alba F
    JAMA Ophthalmol; 2019 Jan; 137(1):117-118. PubMed ID: 30286227
    [No Abstract]   [Full Text] [Related]  

  • 7. Proconvulsant effects of sildenafil citrate on pilocarpine-induced seizures: Involvement of cholinergic, nitrergic and pro-oxidant mechanisms.
    de Carvalho MAJ; Chaves-Filho A; de Souza AG; de Carvalho Lima CN; de Lima KA; Rios Vasconcelos ER; Feitosa ML; Souza Oliveira JV; de Souza DAA; Macedo DS; de Souza FCF; de França Fonteles MM
    Brain Res Bull; 2019 Jul; 149():60-74. PubMed ID: 31004733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma, Viagra, and PDE5 Inhibitors: Proliferation and Metastasis.
    Houslay MD
    Trends Cancer; 2016 Apr; 2(4):163-165. PubMed ID: 28741569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case Report: Consecutive Cranial Neuropathies Following the Use of Phosphodiesterase-5 Inhibitors.
    van Landingham SW; Singman EL
    Am Orthopt J; 2015; 65():109-14. PubMed ID: 26564936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Recurrent Lobar Intracerebral Hemorrhage in the Setting of Phosphodiesterase-5 Inhibitor Use.
    Lucchese SA; Dhaliwal AS; Kaur A; Qi L
    Mo Med; 2019; 116(5):400-403. PubMed ID: 31645793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of hypoglycemia due to illegitimate sexual enhancement medication.
    Kuramoto N; Yabe D; Kurose T; Seino Y
    Diabetes Res Clin Pract; 2015 Apr; 108(1):e8-e10. PubMed ID: 25748828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil related cerebral venous thrombosis following spinal anesthesia.
    Elkoundi A; Tahri A; Meziane M; Bensghir M; Lalaoui SJ
    J Clin Anesth; 2017 Nov; 42():47-48. PubMed ID: 28803125
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of sildenafil in melanoma incidence and mortality.
    Robinson JK
    JAMA Intern Med; 2014 Jun; 174(6):970-1. PubMed ID: 24710720
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxytocin is involved in the proconvulsant effects of Sildenafil: Possible role of CREB.
    Khoshneviszadeh M; Rahimian R; Fakhfouri G; Payandemehr B; Khodagholi F; Ejtemaei Mehr S; Dehpour AR
    Toxicol Lett; 2016 Aug; 256():44-52. PubMed ID: 27220266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Sildenafil in Men With Sexual Dysfunction and Spinal Cord Injury.
    Ohl DA; Carlsson M; Stecher VJ; Rippon GA
    Sex Med Rev; 2017 Oct; 5(4):521-528. PubMed ID: 28341580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PDE-5 inhibitors: patients preferences].
    Efremov EA; Kasatonova EV; Melnik YI; Nikushina AA
    Urologiia; 2017 Jul; (3):120-126. PubMed ID: 28845950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.
    Scaglione F; Donde S; Hassan TA; Jannini EA
    Clin Ther; 2017 Feb; 39(2):370-377. PubMed ID: 28139291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDE-5 inhibitors: clinical points.
    Doumas M; Lazaridis A; Katsiki N; Athyros V
    Curr Drug Targets; 2015; 16(5):420-6. PubMed ID: 25392015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal Toxicity Associated With Excessive Sildenafil Ingestion.
    Brader HS; Athappilly GK; Loewenstein J
    JAMA Ophthalmol; 2019 Mar; 137(3):326-328. PubMed ID: 30629106
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: past, present and future].
    Gamidov SI; Ovchinnikov RI; Popova AY; Izhbaev SK
    Urologiia; 2017 Apr; (1):103-107. PubMed ID: 28394532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.